Lacnotuzumab Uses, Dosage, Side Effects and more
Lacnotuzumab is under investigation in clinical trial NCT01643850 (MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)).
| Trade Name | Lacnotuzumab |
| Generic | Lacnotuzumab |
| Lacnotuzumab Other Names | Lacnotuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
